HepaSH™ Sustainable Human Hepatocytes

Powered by CIEM

Marketed WW by Biopredic International

 

HepaSH™ Technology


Contact Us

HepaSH™ Standardization Technology

HepaSH™ Morphology and Culture Modes

Albumin & HepaSH™

Bile canaliculi in HepaSH™

HepaSH™ Metabolically Competent HH

HepaSH™ CYP Inducibility

Transporters

Contact Us

HepaSH™ Donor Information

Fresh Suspended Ready-to-plate HepaSH™

FSSH001: 5.106 cell/vial  1x 96-multi well plate


  1. Provided as fresh suspended hepatocytes

  2. 3 donors available as of now

    Donor 1: Female, Caucasian, 12 years old. Donor 2: Male, Caucasian, 3 months. Donor 3: Male, Caucasian, 5 years old

  3. William E- based cell culture medium

  4. Can be maintained for up to 14 days in 2D culture

  5. 2 production sessions/month

  6. Our commitments: cell viability, number of viable cells, human cell percentage, sterility

Our services on HepaSH human hepatocytes

Our services on HepaSH human hepatocytes

HepaSH™ Scientific Publications

Discover peer-reviewed publications showcasing the use of HepaSH™ as a human-relevant hepatic model for investigating drug metabolism and pharmacokinetics (DMPK), toxicity, and disease-related mechanisms.

View publications

Contact Us